Latest News

An image of the Capitol building on a cloudless day
Advocacy

Congress Passes Health Extenders and PBM Reform

Here's what HOPA members should know about the end of the recent government shutdown, the resulting appropriations bills passed by Congress, and what the package includes pertaining to health care.

Nurse sitting in hospital hallway resting against a wall
Advocacy

Proposed Student Loan Limits for Nursing and Other Professions Will Contribute to Healthcare Worker Shortages

HOPA is concerned about the Department of Education's proposed language and student loan limits for professions crucial to oncology care, especially nursing. Implementation will contribute to the shortage of healthcare workers in this country.

U.S. Capitol Building
Advocacy

What HOPA Members Should Know About the End of the 2025 U.S. Government Shutdown

On Wednesday, November 12, Congress passed a continuing resolution to re-open the government after a record 43-day shutdown. Here's what HOPA members should know about the bill and what's happening next.

Map of the sub-Saharan African region
Advocacy

HOPA Endorses ISOPP & UICC Statement on Ensuring International Cancer Drug Quality and Equity

ISOPP and UICC recently released a statement calling for quality and equity of cancer treatments in sub-Saharan Africa. HOPA has joined with oncology and pharmacy organizations worldwide to endorse their statement.

Images of DNA strands for DPYD genetic testing
Advocacy

HOPA Supports FDA Box Label Changes for DPYD Testing

We support the FDA's updated guidance concerning DPD deficiency and fluoropyrimidine drugs, and urge healthcare providers to integrate DPYD genetic testing into clinical practice.

Advocacy

What Does the Government Shutdown Mean for Oncology Pharmacists and Our Patients?

The government shutdown affects oncology pharmacists and our patients in a number of ways. This article provides a summary.

A gathering of HOPA members and advocates on the Capitol steps for Hill Day 2025
Advocacy

Record-Breaking Hill Day Participation Brings HOPA Advocacy, Education to D.C.

HOPA members and staff were hard at work in the nation's capital for HOPA Hill Day on Tuesday, Sept. 30, discussing the hem/onc pharmacy profession and the important issues facing optimized cancer care across the nation.

silver-tone rendering of a molecular structure
Advocacy

Oncology Pharmacists Urge Responsible use of Leucovorin

The drug eucovorin is a well-established, essential component of cancer therapy. A surge in demand for leucovorin could lead to supply shortages.

On an orange background, female healthcare workers are huddled in conversation
Advocacy

HOPA Joins Public Awareness Campaign to Increase Visibility of Pharmacists

"We're Your Pharmacist" educates the public about patient care roles in clinical pharmacy and inspires the next generation of pharmacists.

Young man in a pharmacist coat at work
Advocacy Membership

The Role of the IDS Pharmacy Technician

Members of the HOPA Investigational Drug Services (IDS) special interest group (SIG) have identified specific responsibilities and duties that differentiate the IDS technician role from other advanced and specialized technician roles.

Cancer pill medication
Advocacy Membership

HOPA and Coalition to Improve Access to Cancer Care Commend Reintroduction of Cancer Drug Parity Act

HOPA, along with the CIACC, recently voiced its support for the reintroduced Cancer Drug Parity Act, aiming to make oral and self-administered cancer treatments less expensive and more accessible.

HOPA logo
Advocacy

HOPA Signs Letters Defending Medicaid, NIH, and More Against Funding Cuts

HOPA has joined forces with multiple national health organizations to speak out against proposed cuts to Medicaid, the NIH, and the future of optimized cancer care.